Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009 Dec:107:127-33.

Comparative outcomes between newer and older surgeries for glaucoma

Sameh Mosaed  1 , Laurie Dustin, Don S Minckler
Affiliations
Review

Comparative outcomes between newer and older surgeries for glaucoma

Sameh Mosaed et al. Trans Am Ophthalmol Soc. 2009 Dec.

Abstract

Purpose: To compare outcomes across Trabectome, iScience (canaloplasty), trabeculectomy, and aqueous shunts regarding intraocular pressure (IOP), adjunctive medications, and complications after glaucoma-only and combined glaucoma-phacoemulsification surgeries for open-angle glaucomas.

Method: A literature review compares success rates, complications, efficacy, and limitations of traditional and novel glaucoma surgical procedures.

Results: Trabectome and canaloplasty provide modest IOP reduction with minimal intraoperative or postoperative complications. Results of Baerveldt glaucoma implant IOP reduction are comparable to trabeculectomy, but typically this shunt requires more postoperative IOP-lowering medication to achieve a success rate comparable to trabeculectomy.

Conclusion: Trabeculectomy is still the most effective IOP-lowering procedure performed today but continues to have the highest serious complication rates. Trabectome and canaloplasty are reasonable surgical therapy choices for patients in which IOPs in the mid-teens seem adequate.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Intraocular pressure (IOP) during 5-year follow-up in Trabectome-only cases (N = 1287).
FIGURE 2
FIGURE 2
Adjunctive medication use during 5-year follow-up in Trabectome-only cases (N = 1287).
FIGURE 3
FIGURE 3
Intraocular pressure (IOP) during 5-year follow-up in Trabectome-phacoemulsification cases (N = 687).
FIGURE 4
FIGURE 4
Adjunctive medication use during 5-year follow-up in Trabectome-phacoemulsification cases (N = 687)
FIGURE 5
FIGURE 5
Survival curve for Trabectome-only cases (N = 1287).
FIGURE 6
FIGURE 6
Survival curve for combined Trabectome-phacoemulsification cases (N = 687).
See this image and copyright information in PMC

References

    1. Greenfield DS, Suñer IJ, Miller MP, Kangas TA, Palmberg PF, Flynn HW., Jr Endophthalmitis after filtering surgery with mitomycin. Arch Ophthalmol. 1996;114:943–949. - PubMed
    1. Law SK, Nguyen AM, Coleman AL, Caprioli J. Severe loss of central vision in patients with advanced glaucoma undergoing trabeculectomy. Arch Ophthalmol. 2007;125:1044–1055. - PubMed
    1. Gedde SJ, Herndon LW, Brandt JD, Budenz DL, Feuer WJ, Schiffman JC. Surgical complications in the Tube Versus Trabeculectomy Study during the first year of follow-up. Am J Ophthalmol. 2007;143:23–31. - PubMed
    1. Lichter PR, Musch DC, Gillespie BW, et al. CIGTS Study Group Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology. 2001;108:1943–1953. - PubMed
    1. Fluorouracil Filtering Surgery Study Group Five-year follow-up of the Fluorouracil Filtering Surgery Study. Am J Ophthalmol. 1996;121:349–366. - PubMed

MeSH terms